"Teva Pharmaceutical Industries stock gained 0.8% on reports that it's considering the acquisition of rights to Zenvia, a chronic pain medication being developed by a company called Avanir Pharmaceuticals. Alternately, Teva might buy the whole company, lock, stock and barrel."
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.